| Trial ID: | L3362 |
| Source ID: | NCT01812122
|
| Associated Drug: |
Glimepiride
|
| Title: |
Effects of Vildagliptine and Glimepiride on Glucose Variability
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Non-Insulin-Dependent
|
| Interventions: |
DRUG: Glimepiride|DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Glycemic variability index, before and after 3 months of each drug administration|Cardiovascular disease risk factor, before and after 3 months of each drug administration | Secondary: glucose profile and lipid profile, before and after 3 months of each drug administration|hypoglycemic index, before and after 3 months of each drug administration
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-03
|
| Completion Date: |
2015-10
|
| Results First Posted: |
|
| Last Update Posted: |
2015-11-20
|
| Locations: |
Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01812122
|
